Whistler summary: "The slow rate of rapid progress"

Journal of Clinical Gastroenterology

Volumn 41, Issue 6, 2007, Pages 539-545

  Hunt, Richard H ^a   Tytgat, Guido H ^c   Malfertheiner, Peter ^d   Fock, Kwong Ming ^e   Heading, Robert C ^f   Katelaris, Peter H ^g   McCarthy, Denis M ^h   McColl, Kenneth E L ⁱ   Moss, Steven F ^j   Sachs, George ^k   Sontag, Stephen J ^l   Thomson, Alan B R ^b   Modlin, Irvin M ^m,n  

^a MCMASTER UNIVERSITY MEDICAL CENTRE   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

^c UNIVERSITY OF AMSTERDAM   (Netherlands)

^d OTTO VON GUERICKE UNIVERSITY   (Germany)

^e CHANGI GENERAL HOSPITAL   (Singapore)

^f GLASGOW ROYAL INFIRMARY   (United Kingdom)

^g UNIVERSITY OF SYDNEY   (Australia)

^h UNIVERSITY OF NEW MEXICO   (United States)

ⁱ WESTERN INFIRMARY   (United Kingdom)

^j BROWN UNIVERSITY   (United States)

^k UNIVERSITY OF CALIFORNIA   (United States)

^l VETERANS AFFAIRS MEDICAL CENTER   (United States)

^m YALE UNIVERSITY   (United States)

ⁿ YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BACLOFEN; PROTON PUMP INHIBITOR;

BARRETT ESOPHAGUS; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; DIET; DRUG HALF LIFE; EDITORIAL; ENDOSCOPY; ESOPHAGUS CANCER; ESOPHAGUS MUCOSA; ESOPHAGUS PH; GASTROESOPHAGEAL REFLUX; HEALTH CARE COST; HEARTBURN; HELICOBACTER PYLORI; HUMAN; INCIDENCE; LOWER ESOPHAGUS SPHINCTER; OBESITY; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; QUALITY OF LIFE; STOMACH PH; UNSPECIFIED SIDE EFFECT;

GASTROESOPHAGEAL REFLUX; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; PROTON PUMPS;

EID: 34250714474     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/MCG.0b013e31803d0fd8     Document Type: Editorial

References (29)

1. Fock KM, Talley N, Hunt R, et al. Report of the Asia-Pacific consensus on the management of gastroesophageal reflux disease. J Gastroenterol Hepatol. 2004;19:357-367.
2. Shaheen NJ, Hansen RA, Morgan DR, et al. The burden of gastrointestinal and liver diseases, 2006. Am J Gastroenterol. 2006;101:2128-2138.
3. Hampel H, Abraham NS, El-Serag HB. Meta-analysis: obesity and the risk for gastroesophageal reflux disease and its complications. Ann Intern Med. 2005;143:199-211.
4. Moayyedi P, Talley NJ. Gastro-oesophageal reflux disease. Lancet. 2006;367:2086-2100.
5. Jacobson BC, Somers SC, Fuchs CS, et al. Body-mass index and symptoms of gastroesophageal reflux in women. N Engl J Med. 2006;354:2340-2348.
6. Thomson AB, Barkun AN, Armstrong D, et al. The prevalence of clinically significant endoscopic findings in primary care patients with uninvestigated dyspepsia: the Canadian Adult Dyspepsia Empiric Treatment-Prompt Endoscopy (CADET-PE) study. Aliment Pharmacol Ther. 2003;17:1481-1491.
7. McColl KEL. Review article: Helicobacter pylori and gastroesophageal reflux disease - the European perspective. Aliment Pharmacol Ther. 2004;20(suppl 8):36-39.
8. Shaker R, Castell DO, Schoenfeld PS, et al. Nighttime heartburn is an under-appreciated clinical problem that impacts sleep and daytime function: the results of a Gallup survey conducted on behalf of the American Gastroenterological Association. Am J Gastroenterol. 2003;98:1487-1493.
9. Orr WC, Heading R, Johnson LF, et al. Review article: sleep and its relationship to gastro-oesophageal reflux. Aliment Pharmacol Ther. 2004;20(suppl 9):39-46.
10. Dent J, Brun J, Fendrick AM, et al. An evidence-based appraisal of reflux disease management - the Genval Workshop Report. Gut. 1999;44(suppl 2):S1-16.
11. Vakil N, van Zanten SV, Kahrilas P, et al, Global Consensus Group. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol. 2006;101:1900-1920.
12. Stanghellini V, Armstrong D, Monnikes H, et al. Systematic review: do we need a new gastro-oesophageal reflux disease questionnaire? Aliment Pharmacol Ther. 2004;19:463-479.
13. Armstrong D, Monnikes H, Bardhan KD, et al. The construction of a new evaluative GERD questionnaire - methods and state of the art. Digestion. 2004;70:71-78.
14. Quigley EM. Functional dyspepsia (FD) and non-erosive reflux disease (NERD): overlapping or discrete entities? Best Pract Res Clin Gastroenterol. 2004;18:695-706.
15. Armstrong D, Talley NJ, Lauritsen K, et al. The role of acid suppression in patients with endoscopy-negative reflux disease: the effect of treatment with esomeprazole or omeprazole. Aliment Pharmacol Ther. 2004;20:413-421.
16. Numans ME, Lau J, de Wit NJ, et al. Short-term treatment with proton-pump inhibitors as a test for gastroesophageal reflux disease: a meta-analysis of diagnostic test characteristics. Ann Intern Med. 2004;140:518-527.
17. Monnikes H. The complete remission concept. Drugs Today. 2006;42(suppl B):9-14.
18. Kern MK, Birn RM, Jaradeh S, et al. Identification and characterization of cerebral cortical response to esophageal mucosal acid exposure and distention. Gastroenterology. 1998;115:1353-1362.
19. Sarkar S, Aziz Q, Woolf CJ, et al. Contribution of central sensitisation to the development of non-cardiac chest pain. Lancet. 2000;356:1154-1159.
20. Geeraerts B, Vandenberghe J, Van Oudenhove L, et al. Influence of experimentally induced anxiety on gastric sensorimotor function in humans. Gastroenterology. 2005;129:1437-1444.
21. Pandolfino JE, Shi G, Trueworthy B, Kahrilas PJ. Esophagogastric junction opening during relaxation distinguishes nonhernia reflux patients, hernia patients, and normal subjects. Gastroenterology. 2003;125:1018-1024.
22. Jankowski J. MSc thesis. University of Oxford, UK 2006. 2007. In press.
23. Avidan B, Sonnenberg A, Chejfec G, et al. Is there a link between cervical inlet patch and Barrett's esophagus? Gastrointest Endosc. 2001;53:717-721.
24. El-Serag HB, Aguirre TV, Davis S, et al. Proton pump inhibitors are associated with reduced incidence of dysplasia in Barrett's esophagus. Am J Gastroenterol. 2004;99:1877-1883.
25. http://pfsearch.ukcrn.org.uk/StudyDetail.aspx?TopicID=1&StudyID=1339. Accessed November 15, 2006.
26. McColl KE. When saliva meets acid: chemical warfare at the oesophagogastric junction. Gut. 2005;54:1-3.
27. Hunt RH, Armstrong D, James C, et al. Effect on intragastric pH of a PPI with a prolonged plasma half-life: comparison between tenatoprazole and esomeprazole on the duration of acid suppression in healthy male volunteers. Am J Gastroenterol. 2005;100:1949-1956.
28. Vakil N, Shaw M, Kirby R. Clinical effectiveness of laparoscopic fundoplication in a U.S. community. Am J Med. 2003;114:1-5.
29. Hogan WJ. Clinical trials evaluating endoscopic GERD treatments: Is it time for a moratorium on the clinic use of these procedure? Am J Gastroenterol. 2006;101:437-439.